Sylph Industries Ltd vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Sylph Industries Ltd is ₹ 0.16 as of 23 Oct 15:30 . The P/E Ratio of Sylph Industries Ltd is 0 as of March 2025 .The P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd is 0 as of March 2025 . The Market Cap of Sylph Industries Ltd is ₹ 35.51 crore as of March 2025 .The Market Cap of Welcure Drugs & Pharmaceuticals Ltd is ₹ 0 crore as of March 2025 . The revenue of Sylph Industries Ltd for the Jun '26 is ₹ 6.18 crore as compare to the Mar '26 revenue of ₹ 25.78 crore. This represent the decline of -76.03% The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Sylph Industries Ltd for the Jun '26 is ₹ 0.39 crore as compare to the Mar '26 ebitda of ₹ 1.26 crore. This represent the decline of -69.05% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Sylph Industries Ltd changed from ₹ 0.52 crore to ₹ 0.39 crore over 9 quarters. This represents a CAGR of -12.00% The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Sylph Industries Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Sylph Industries Ltd

Sylph Technologies Limited was incorporated in May, 1992.
Sylph is a leading software technology company in India, providing software development services & solutions with services such as Outsourcing Software Development, Web Development, Product Development, Strategy Consulting, Offshore Software Development, E-Commerce for Web and Mobile Enablement.
The Company has also engaged in the distribution of a 25 year old Newspaper. Company operates in four segments namely Information Technology, Education, Printing and Publishing Newspapers and Trading of Solar Power Plant.
The Company started warehousing business and the business of Education through IT during year 2010-11.
In 2015, it launched BPO Service & KPO Service; and later on, started trading of Solar Power Product in 2018. The Company delivers higher value returns through cutting edge expertise and offshore outsourcing and software outsourcing solutions for business and technology requirements.

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

FAQs for the comparison of Sylph Industries Ltd and Welcure Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Sylph Industries Ltd or Welcure Drugs & Pharmaceuticals Ltd?

Market cap of Sylph Industries Ltd is 19 Cr while Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr

What are the key factors driving the stock performance of Sylph Industries Ltd and Welcure Drugs & Pharmaceuticals Ltd?

The stock performance of Sylph Industries Ltd and Welcure Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sylph Industries Ltd and Welcure Drugs & Pharmaceuticals Ltd?

As of October 25, 2026, the Sylph Industries Ltd stock price is INR ₹0.16. On the other hand, Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18.

How do dividend payouts of Sylph Industries Ltd and Welcure Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Sylph Industries Ltd and Welcure Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.